Equities

Hin Sang Group (International) Holding Co Ltd

Hin Sang Group (International) Holding Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)0.28
  • Today's Change0.00 / 0.00%
  • Shares traded22.00k
  • 1 Year change-27.27%
  • Beta0.2260
Data delayed at least 15 minutes, as of Jun 06 2024 08:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hin Sang Group (International) Holding Co. Ltd. is an investment holding company principally engaged in development, marketing and sales of care products, healthcare products and household products under various brands. The Company operates its business through three segments. The Product Development segment is engaged in the sales of products developed by the Company under own brands. The Brand Development and Management segment is engaged in the sales and distribution of products with exclusive distribution rights. The Trading of Goods segment is engaged in the sales and distribution of products purchased from authorized dealers, independent traders, manufacturers and parallel importers.

  • Revenue in HKD (TTM)92.79m
  • Net income in HKD-35.72m
  • Incorporated2010
  • Employees265.00
  • Location
    Hin Sang Group (International) Holding Co LtdFlat B, 12/F., Hi-Tech Centre11 Wang Yip Street WestYuen Long, New Territories Hong KongHKG
  • Websitehttps://www.hinsanggroup.com/en/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Extrawell Pharmaceutical Holdings Ltd68.62m-154.28m88.43m169.00--0.085--1.29-0.0776-0.07760.02090.43540.05387.479.89379,132.60-12.004.62-12.504.8847.3651.97-223.0773.993.38-0.05140.09680.00-1.82-3.28-1.0133.99121.54--
Sanai Health Industry Group Co Ltd131.83m20.12m103.21m68.004.880.30365.790.78290.00550.00550.03480.0890.3179188.038.441,938,742.003.482.314.723.6528.7734.8710.956.566.22--0.18810.00-30.6016.04-36.23---75.21--
BioSino Bio-technology and Science Inc312.12m-12.58m104.19m537.00--0.4587--0.3338-0.0869-0.08692.161.570.49562.791.46581,237.60-3.30-3.84-8.55-10.1744.0640.17-6.66-6.980.9033--0.3956---22.52-0.9513-243.70---16.58--
China Health Group Inc23.13m-62.85m111.48m42.00--1.22--4.82-0.0631-0.06310.02320.0920.1438--0.246550,797.60-39.076.84-51.269.5238.3374.98-271.7019.19----0.000.0063.67-18.51-267.82--30.37--
Regent Pacific Group Ltd2.48m-195.87m132.47m17.00------53.44-0.87-0.870.011-0.05310.0218--12.19145,810.70-172.08-50.00-694.26-59.04-----7,901.89-2,685.21--------574.47-44.7231.24---50.60--
Canbridge Pharmaceuticals Inc111.07m-409.05m144.45m100.00------1.30-0.9639-0.96390.2617-0.10120.18754.164.091,110,743.00-69.04---154.20--62.37---368.26--0.6132-41.341.39--30.26--21.64------
Kontafarma China Holdings Ltd809.11m-28.84m184.42m720.00--0.17444.170.2279-0.0052-0.00520.1450.18920.42063.227.031,123,760.00-3.18-1.33-4.22-2.1858.2554.70-7.55-4.121.28-17.160.2392---9.50-17.3266.02---19.55--
Modern Chinese Medicine Group Co Ltd371.51m52.69m228.00m191.004.330.44653.850.61370.08780.08780.61920.8510.66815.453.801,945,092.009.4720.7610.7525.8230.2841.0214.1820.117.98206.120.00022.54-13.9114.67-44.440.230396.96--
Wai Yuen Tong Medicine Holdings Limited1.36bn36.42m252.02m1.96k7.400.11791.470.18540.03030.03031.131.900.20140.42422.81700,208.600.8907-0.07331.54-0.119649.0842.524.42-0.4560.56631.490.31960.00-7.558.7581.16---12.06--
Shenzhen Neptunus Intrlng Bi tchnq CoLtd1.13bn29.33m253.38m1.44k8.64--11.580.22450.01750.01750.6727--------781,746.00--3.46--5.1339.4849.141.464.29--109.94--0.007.924.19-55.60-12.89-11.10--
PuraPharm Corp Ltd406.86m-106.08m292.96m662.00--1.91--0.7201-0.2685-0.26851.030.38710.43741.044.21614,590.60-11.40-9.20-34.00-19.7053.2459.52-26.07-19.330.3046-2.020.7349---9.20-11.4111.76---13.68--
Hin Sang Group (Interntnl) Hldng Co Ltd92.79m-35.72m311.16m265.00--1.41--3.35-0.0327-0.03270.0850.2020.15242.299.49366,766.80-5.81-4.06-8.74-5.2655.9561.98-38.14-20.980.1129-1.150.5766---32.42-15.45-315.54---36.30--
Uni-Bio Science Group Ltd484.72m70.88m425.29m407.006.191.684.850.87740.01110.01110.07620.0411.382.6213.501,190,953.0020.181.4628.501.9781.0480.5914.621.231.7697.930.17960.0010.0829.0884.04--84.98--
Data as of Jun 06 2024. Currency figures normalised to Hin Sang Group (International) Holding Co Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.